Creatine Ethyl Ester: A New Substrate for Creatine Kinase

被引:2
|
作者
Ravera, S. [1 ]
Adriano, E. [2 ]
Balestrino, M. [2 ]
Panfoli, I. [1 ]
机构
[1] Univ Genoa, Dept Biol, I-316132 Genoa, Italy
[2] Univ Genoa, Dept Neurosci Ophthalmol & Genet, I-16132 Genoa, Italy
关键词
creatine; creatine ethyl ester; creatine phosphokinase; phosphocreatine; phosphagene; RAT-BRAIN; METABOLISM; COMPARTMENTATION; EXPRESSION; TRANSPORT; TISSUES; ATP;
D O I
10.1134/S0026893312010190
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The creatine kinase/phosphocreatine system plays a key role in cell energy buffering and transport, particularly in cells with high or fluctuating energy requirements, like neurons, i.e. it participates in the energetic metabolism of the brain. Creatine depletion causes several nervous system diseases, alleviated by phosphagen supplementation. Often, the supplementation contains both creatine and creatine ethyl ester, known to improve the effect of creatine through an unknown mechanism. In this work we showed that purified creatine kinase is able to phosphorilate the creatine ethyl ester. The K-m and V-max values, as well as temperature and pH optima were determined. Conversion of the creatine ethyl ester into its phosphorylated derivative, sheds light on the role of the creatine ethyl ester as an energy source in supplementation for selected individuals. DOI: 10.1134/S0026893312010190
引用
收藏
页码:149 / 152
页数:4
相关论文
共 50 条
  • [31] TETRATHIONATE-BLOCKED CREATINE-KINASE AS A SUBSTRATE FOR HUMAN-PLASMA CREATINE-KINASE CONVERSION FACTOR
    EDWARDS, RJ
    WATTS, DC
    [J]. CLINICA CHIMICA ACTA, 1983, 133 (03) : 275 - 283
  • [33] Changing the substrate specificity of creatine kinase from creatine to glycocyamine: Evidence for a highly evolved active site
    Jourden, Michael J.
    Clarke, Callisia N.
    Palmer, Allyson K.
    Barth, Emily J.
    Prada, Rebecca C.
    Hale, Robyn N.
    Fraga, Dean
    Snider, Mark J.
    Edmiston, Paul L.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2007, 1774 (12): : 1519 - 1527
  • [34] Clinical Evaluation of a New Creatine Kinase MB Activity Reagent Abrogating the Effect of Mitochondrial Creatine Kinase
    Hoshino, Tadashi
    Sakai, Yasuhiro
    Yamashita, Kazuaki
    Kishi, Kouji
    Tanjoh, Katsuhisa
    Hirayama, Atsushi
    Nakayama, Tomohiro
    [J]. CLINICAL LABORATORY, 2013, 59 (3-4) : 307 - 316
  • [36] Changing the Substrate Specificity of Creatine Kinase from Creatine to Glycocyamine: Evidence for a Highly Evolved Active Site
    Barth, Emily J.
    Fraga, Dean
    Edmiston, Paul L.
    [J]. FASEB JOURNAL, 2008, 22
  • [37] Creatine kinase gene mutation in a patient with muscle creatine kinase deficiency
    Yamamichi, H
    Kasakura, S
    Yamamori, S
    Iwasaki, R
    Jikimoto, T
    Kanagawa, S
    Ohkawa, J
    Kumagai, S
    Koshiba, M
    [J]. CLINICAL CHEMISTRY, 2001, 47 (11) : 1967 - 1973
  • [38] The creatine kinase conundrum: a reappraisal of the association of isotretinoin, creatine kinase, and rhabdomyolysis
    Marson, Justin W.
    Baldwin, Hilary E.
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (03) : 279 - 283
  • [39] Macro-creatine kinase: a neglected cause of elevated creatine kinase
    Aljuani, F.
    Tournadre, A.
    Cecchetti, S.
    Soubrier, M.
    Dubost, J. J.
    [J]. INTERNAL MEDICINE JOURNAL, 2015, 45 (04) : 457 - 459
  • [40] Creatine kinase, not creatinine kinase
    Jefferson, JW
    Aga, VM
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (06) : 668 - 668